Note: The vaccination schedules shown below are those reflected in the IMCI chart booklets of countries. To see the latest national vaccination schedules, including the introduction of new vaccines, click on this link:
WHO vaccine-preventable diseases: monitoring system. 2013 global summary
| Afghanistan |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
|
|
| 10 weeks: |
DPT2 |
OPV2 |
|
|
|
| 14 weeks: |
DPT3 |
OPV3 |
|
|
|
| 9 months *: |
Measles |
OPV4 |
|
|
|
| Djibouti |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
|
|
| 10 weeks: |
DPT2 |
OPV2 |
|
|
|
| 14 weeks: |
DPT3 |
OPV3 |
|
|
|
| 9 months *: |
Measles |
|
|
|
|
| Egypt |
By 3 months: |
BCG |
|
|
|
|
|---|
| 2 months: |
DPT1 |
OPV1 |
|
HepB1 |
|
| 4 months: |
DPT2 |
OPV2 |
|
HepB2 |
|
| 6 months: |
DPT3 |
OPV3 |
|
HepB3 |
|
| 9 months: |
Measles |
OPV4 |
|
|
|
| 18 months: |
DPT & OPV boosters, MMR |
|
|
| Iran (Islamic Republic of) |
Birth: |
BCG |
OPV0 |
|
HepB1 |
|
|---|
| 2 months: |
DPT1 |
OPV1 |
|
HepB2 |
|
| 4 months: |
DPT2 |
OPV2 |
|
|
|
| 6 months: |
DPT3 |
OPV3 |
|
HepB3 |
|
| 12 months: |
MMR |
|
|
|
|
| 18 months: |
DPT & OPV boosters |
|
|
| 4-6 years: |
DPT & OPV boosters, MMR |
|
|
| Morocco |
Birth: |
BCG |
OPV0 |
|
HepB1 |
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
HepB2 |
Hib1 |
| 10 weeks: |
DPT2 |
OPV2 |
|
|
Hib2 |
| 14 weeks: |
DPT3 |
OPV3 |
|
|
Hib3 |
| 9 months: |
Measles |
|
|
HepB3 |
|
| 18 months: |
DPT & OPV boosters |
|
|
| Occupied Palestinian territory |
Birth: |
BCG |
|
|
HepB1 |
|
|---|
| 1 month after 1st visit: |
|
|
IPV1 |
HepB2 |
Hib1 |
| 2 months: |
DPT1 |
OPV1 |
IPV2 |
|
Hib2 |
| 4 months: |
DPT2 |
OPV2 |
|
|
Hib3 |
| 6 months: |
DPT3 |
OPV3 |
|
HepB3 |
|
| 9 months: |
Measles |
|
|
|
|
| 12 months: |
DPT4 |
OPV4 booster |
|
|
| 15 months: |
MMR |
|
|
|
|
| Oman |
Birth: |
BCG |
OPV0 |
|
HepB1 |
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
HepB2 |
|
| 3 months: |
DPT2 |
OPV2 |
|
|
Meningitis-1 |
| 5 months: |
DPT3 |
OPV3 |
|
|
Meningitis-2 |
| 7 months: |
|
OPV4 |
|
HepB3 |
Meningitis-3 |
| 12 months: |
Measles |
|
|
|
|
| 18 months: |
DPT & OPV boosters, MMR |
|
|
| Pakistan |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
Penta1* |
OPV1 |
|
(HepB1)* |
(Hib1)* |
| 10 weeks: |
Penta2* |
OPV2 |
|
(HepB2)* |
(Hib2)* |
| 14 weeks: |
Penta3* |
OPV3 |
|
(HepB3)* |
(Hib3)* |
| 9 months: |
Measles1 |
|
|
|
|
| 15 months: |
Measles2 |
|
|
|
|
| Sudan |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
Penta1* |
OPV1 |
|
(HepB1)* |
(Hib1)* |
| 10 weeks: |
Penta2* |
OPV2 |
|
(HepB2)* |
(Hib2)* |
| 14 weeks: |
Penta3* |
OPV3 |
|
(HepB3)* |
(Hib3)* |
| 9 months: |
Measles |
|
|
|
|
| Syrian Arab Republic |
1st week: |
BCG |
|
|
HepB1 |
|
|---|
| 3 months: |
Penta* |
IPV1 |
|
(HepB2)* |
(Hib1)* |
| 4 months: |
Tetra* |
IPV2 |
|
|
(Hib2)* |
| 5 months: |
Tetra* |
OPV1 |
|
|
(Hib3)* |
| 7 months: |
|
OPV2 |
|
HepB3 |
|
| 12 months: |
MMR1 |
OPV3 |
|
|
|
| 18 months: |
Tetra*, MMR2 |
OPV4 |
|
|
(Hib4)* |
| Tunisia |
Birth: |
BCG |
|
|
|
|
|---|
| 3 months: |
DPT1 |
OPV1 |
|
HepB1 |
Hib1 |
| 4 months: |
DPT2 |
OPV2 |
|
HepB2 |
Hib2 |
| 5 months: |
DPT3 |
OPV3 |
|
|
Hib3 |
| 9 months: |
|
|
|
HepB3 |
|
| 15 months: |
Measles |
|
|
|
|
| 18 months: |
DPT & OPV boosters |
|
|
| Yemen |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
Penta1 |
OPV1 |
|
(HepB1)* |
(Hib1)* |
| 10 weeks: |
Penta2 |
OPV2 |
|
(HepB2)* |
(Hib2)* |
| 14 weeks: |
Penta3 |
OPV3 |
|
(HepB3)* |
(Hib3)* |
| 9 months: |
Measles1 |
|
|
|
|
| 18 months: |
Measles2 |
|
|
|
|
BCG=Bacille Calmette-Guèrin; OPV=Oral Polio Virus; DPT=Diphtheria, Tetanus and Pertussis [whooping cough];
HepB=Hepatitis B; Hib=Haemophilus influenzae type b; Penta= diphtheria, pertussis, tetanus, haemophilus influenza type B and hepatitis B; Tetra = diphtheria, pertussis, tetanus, haemophilus influenza type B; MMR=Measles, Mumps and Rubella
( )* Included in the Penta- or Tetravalent vaccine
Note: The vaccination schedules shown below are those reflected in the IMCI chart booklets of countries. To see the latest national vaccination schedules, including the introduction of new vaccines, click on this link:
WHO vaccine-preventable diseases: monitoring system. 2013 global summary
| Afghanistan |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
|
|
| 10 weeks: |
DPT2 |
OPV2 |
|
|
|
| 14 weeks: |
DPT3 |
OPV3 |
|
|
|
| 9 months *: |
Measles |
OPV4 |
|
|
|
| Djibouti |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
|
|
| 10 weeks: |
DPT2 |
OPV2 |
|
|
|
| 14 weeks: |
DPT3 |
OPV3 |
|
|
|
| 9 months *: |
Measles |
|
|
|
|
| Egypt |
By 3 months: |
BCG |
|
|
|
|
|---|
| 2 months: |
DPT1 |
OPV1 |
|
HepB1 |
|
| 4 months: |
DPT2 |
OPV2 |
|
HepB2 |
|
| 6 months: |
DPT3 |
OPV3 |
|
HepB3 |
|
| 9 months: |
Measles |
OPV4 |
|
|
|
| 18 months: |
DPT & OPV boosters, MMR |
|
|
| Iran (Islamic Republic of) |
Birth: |
BCG |
OPV0 |
|
HepB1 |
|
|---|
| 2 months: |
DPT1 |
OPV1 |
|
HepB2 |
|
| 4 months: |
DPT2 |
OPV2 |
|
|
|
| 6 months: |
DPT3 |
OPV3 |
|
HepB3 |
|
| 12 months: |
MMR |
|
|
|
|
| 18 months: |
DPT & OPV boosters |
|
|
| 4-6 years: |
DPT & OPV boosters, MMR |
|
|
| Morocco |
Birth: |
BCG |
OPV0 |
|
HepB1 |
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
HepB2 |
Hib1 |
| 10 weeks: |
DPT2 |
OPV2 |
|
|
Hib2 |
| 14 weeks: |
DPT3 |
OPV3 |
|
|
Hib3 |
| 9 months: |
Measles |
|
|
HepB3 |
|
| 18 months: |
DPT & OPV boosters |
|
|
| Occupied Palestinian territory |
Birth: |
BCG |
|
|
HepB1 |
|
|---|
| 1 month after 1st visit: |
|
|
IPV1 |
HepB2 |
Hib1 |
| 2 months: |
DPT1 |
OPV1 |
IPV2 |
|
Hib2 |
| 4 months: |
DPT2 |
OPV2 |
|
|
Hib3 |
| 6 months: |
DPT3 |
OPV3 |
|
HepB3 |
|
| 9 months: |
Measles |
|
|
|
|
| 12 months: |
DPT4 |
OPV4 booster |
|
|
| 15 months: |
MMR |
|
|
|
|
| Oman |
Birth: |
BCG |
OPV0 |
|
HepB1 |
|
|---|
| 6 weeks: |
DPT1 |
OPV1 |
|
HepB2 |
|
| 3 months: |
DPT2 |
OPV2 |
|
|
Meningitis-1 |
| 5 months: |
DPT3 |
OPV3 |
|
|
Meningitis-2 |
| 7 months: |
|
OPV4 |
|
HepB3 |
Meningitis-3 |
| 12 months: |
Measles |
|
|
|
|
| 18 months: |
DPT & OPV boosters, MMR |
|
|
| Pakistan |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
Penta1* |
OPV1 |
|
(HepB1)* |
(Hib1)* |
| 10 weeks: |
Penta2* |
OPV2 |
|
(HepB2)* |
(Hib2)* |
| 14 weeks: |
Penta3* |
OPV3 |
|
(HepB3)* |
(Hib3)* |
| 9 months: |
Measles1 |
|
|
|
|
| 15 months: |
Measles2 |
|
|
|
|
| Sudan |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
Penta1* |
OPV1 |
|
(HepB1)* |
(Hib1)* |
| 10 weeks: |
Penta2* |
OPV2 |
|
(HepB2)* |
(Hib2)* |
| 14 weeks: |
Penta3* |
OPV3 |
|
(HepB3)* |
(Hib3)* |
| 9 months: |
Measles |
|
|
|
|
| Syrian Arab Republic |
1st week: |
BCG |
|
|
HepB1 |
|
|---|
| 3 months: |
Penta* |
IPV1 |
|
(HepB2)* |
(Hib1)* |
| 4 months: |
Tetra* |
IPV2 |
|
|
(Hib2)* |
| 5 months: |
Tetra* |
OPV1 |
|
|
(Hib3)* |
| 7 months: |
|
OPV2 |
|
HepB3 |
|
| 12 months: |
MMR1 |
OPV3 |
|
|
|
| 18 months: |
Tetra*, MMR2 |
OPV4 |
|
|
(Hib4)* |
| Tunisia |
Birth: |
BCG |
|
|
|
|
|---|
| 3 months: |
DPT1 |
OPV1 |
|
HepB1 |
Hib1 |
| 4 months: |
DPT2 |
OPV2 |
|
HepB2 |
Hib2 |
| 5 months: |
DPT3 |
OPV3 |
|
|
Hib3 |
| 9 months: |
|
|
|
HepB3 |
|
| 15 months: |
Measles |
|
|
|
|
| 18 months: |
DPT & OPV boosters |
|
|
| Yemen |
Birth: |
BCG |
OPV0 |
|
|
|
|---|
| 6 weeks: |
Penta1 |
OPV1 |
|
(HepB1)* |
(Hib1)* |
| 10 weeks: |
Penta2 |
OPV2 |
|
(HepB2)* |
(Hib2)* |
| 14 weeks: |
Penta3 |
OPV3 |
|
(HepB3)* |
(Hib3)* |
| 9 months: |
Measles1 |
|
|
|
|
| 18 months: |
Measles2 |
|
|
|
|
BCG=Bacille Calmette-Guèrin; OPV=Oral Polio Virus; DPT=Diphtheria, Tetanus and Pertussis [whooping cough];
HepB=Hepatitis B; Hib=Haemophilus influenzae type b; Penta= diphtheria, pertussis, tetanus, haemophilus influenza type B and hepatitis B; Tetra = diphtheria, pertussis, tetanus, haemophilus influenza type B; MMR=Measles, Mumps and Rubella
( )* Included in the Penta- or Tetravalent vaccine
